Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Correspondence
  • Published:

Retrospective institutional analysis of fludarabine/8 Gy TBI reduced intensity conditioning in high risk ALL

Bone Marrow Transplantation volume 55, pages 2185–2187 (2020)Cite this article

Subjects

Allogeneic stem cell transplantation (AlloHSCT) remains treatment modality for ALL at high risk of relapse. TBI-based transplant conditioning regimes are frequently used and associated with better progression free survival (PFS) in ALL patients [1,2,3].

In an intention to treat analysis, we studied consecutively treated high risk ALL patients who received reduced intensity fractionated 8 Gy of TBI with fludarabine and matched or haplo-identical PBSC graft from June 2016 till Apr 2019 for outcome.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Tanaka J, Kanamori H, Nishiwaki S, Ohashi K, Taniguchi S, Eto T, et al. Reduced-intensity vs myeloablative conditioning allogeneic hematopoietic SCT for patients aged over 45 years with ALL in remission: a study from the Adult ALL Working Group of the Japan Society for Hematopoietic Cell Transplantation (JSHCT). Bone Marrow Transpl. 2013;48:1389–94.

    Article  CAS  Google Scholar 

  2. Marks DI, Wang T, Perez WS, Antin JH, Copelan E, Gale RP, et al. The outcome of full-intensity and reduced-intensity conditioning matched sibling or unrelated donor transplantation in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia in first and second complete remission. Blood. 2010;116:366–74.

    Article  CAS  Google Scholar 

  3. Mohty M, Labopin M, Volin L, Gratwohl A, Socié G, Esteve J, et al. Reduced intensity versus conventional myeloablative conditioning allogeneic stem cell transplantation for patients with acute lymphoblastic leukemia: a retrospective study from the European Group for Blood and Marrow Transplantation. Blood. 2010;116:4439–43.

    Article  CAS  Google Scholar 

  4. Stelljes M, Bornhauser M, Kroger M, Beyer J, Sauerland MC, Heinecke A, et al. Conditioning with 8-Gy total body irradiation and fludarabine for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia. Blood. 2005;106:3314–21.

    Article  CAS  Google Scholar 

  5. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457–81.

    Article  Google Scholar 

  6. Gooley TA, Leisenring W, Crowley J, Storer BE. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med. 1999;18:695–706.

    Article  CAS  Google Scholar 

  7. Davidson-Pilon C, Kalderstam J, Zivich P, Ben K, Andrew F-G, Luis M, et al. (2019). CamDavidsonPilon/lifelines: v0.22.5 (Version v0.22.5). Zenodo. https://doi.org/10.5281/zenodo.3454676C.

  8. Clift RA, Buckner CD, Appelbaum FR, Sullivan KM, Storb R, Thomas ED. Long-term follow-up of a randomized trial of two irradiation regimens for patients receiving allogeneic marrow transplants during first remission of acute myeloid leukemia. Blood. 2002;30:717–23.

    Google Scholar 

  9. Arai Y, Kondo T, Shigematsu A, Tanaka J, Ohashi K, Fukuda T, et al. Improved prognois with additional medium‐dose VP16 to CY/TBI in allogeneic transplantation for high risk ALL in adults. Am J Hematol. 2018;93:47–57.

    Article  CAS  Google Scholar 

  10. Marks DI, Forman SJ, Blume KG, Pérez WS, Weisdorf DJ, Keating A, et al. A comparison of cyclophosphamide and total body irradiation with etoposide and total body irradiation as conditioning regimens for patients undergoing sibling allografting for acute lymphoblastic leukemia in first or second complete remission. Biol Blood Marrow Transpl. 2006;12:438–53.

    Article  CAS  Google Scholar 

  11. Nair AP, Fleming S, Avery S, Curtis DJ, Patil SS, Walker PA, et al. Comparison of cyclophosphamide/total body irradiation (Cy/TBI) and etoposide/total body irradiation (Etop/TBI) conditioned allogeneic stem cell transplant (alloHSCT) for adult acute lymphoblastic leukaemia (ALL), data from an Australian Tertiary Care Centre. Blood. 2015;126:5543.

    Article  Google Scholar 

Download references

Acknowledgements

We would like to acknowledge Ms. Niharika Bhatia for her constant support in data collection. We would like to sincerely thank Mr. Sherin P Babu and Bone Marrow Transplant nursing team, Rajiv Gandhi Cancer Institute and Research Centre, India for proper maintenance of patient records. We would like to thank all the staff and members of Department of Hematology and Bone Marrow Transplant, Rajiv Gandhi Cancer Institute and Research Centre, India for their support.

Author information

Authors and Affiliations

  1. Department of Hematology and Bone Marrow Transplant Unit, Rajiv Gandhi Cancer Institute and Research Centre, New Delhi, India

    Jyotsna Kapoor, Pragya Agrawal, Vishvdeep Khushoo, Faran Naim, Sumeet P. Mirgh, Rayaz Ahmed, Dinesh Bhurani & Narendra Agrawal

  2. Department of Hematology, Army Hospital (Research and Referral), New Delhi, India

    Suman Kumar Pramanik

Authors
  1. Jyotsna Kapoor
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Suman Kumar Pramanik
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Pragya Agrawal
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Vishvdeep Khushoo
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Faran Naim
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Sumeet P. Mirgh
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Rayaz Ahmed
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Dinesh Bhurani
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Narendra Agrawal
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Narendra Agrawal.

Ethics declarations

Conflict of interest

All authors declare that they do not have any competing financial interests to the work described.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kapoor, J., Pramanik, S.K., Agrawal, P. et al. Retrospective institutional analysis of fludarabine/8 Gy TBI reduced intensity conditioning in high risk ALL. Bone Marrow Transplant 55, 2185–2187 (2020). https://doi.org/10.1038/s41409-020-0898-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41409-020-0898-1

This article is cited by

Search

Advanced search

Quick links